KIMIA BIOSCIENCES Financial Statement Analysis
|
||
|
The Revenues of KIMIA BIOSCIENCES have increased by 2.89% YoY .
The Earnings Per Share (EPS) of KIMIA BIOSCIENCES has decreased by Negative YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
KIMIA BIOSCIENCES Last 5 Annual Financial Results
[BOM: 530313]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹129 Cr | ₹125 Cr | ₹133 Cr | ₹106 Cr | ₹94 Cr |
| Expenses | ₹134 Cr | ₹124 Cr | ₹124 Cr | ₹102 Cr | ₹88 Cr |
| Operating Profit (Excl OI) | ₹-5.09 Cr | ₹0.63 Cr | ₹8.38 Cr | ₹4.45 Cr | ₹5.57 Cr |
| Other Income | ₹1.33 Cr | ₹0.93 Cr | ₹2.46 Cr | ₹0.96 Cr | ₹1.33 Cr |
| Interest | ₹4.25 Cr | ₹3.64 Cr | ₹3.39 Cr | ₹2.53 Cr | ₹2.00 Cr |
| Depreciation | ₹3.33 Cr | ₹2.94 Cr | ₹1.91 Cr | ₹1.66 Cr | ₹1.10 Cr |
| Profit Before Tax | ₹-12 Cr | ₹-5.02 Cr | ₹5.53 Cr | ₹1.23 Cr | ₹3.81 Cr |
| Profit After Tax | ₹-9.35 Cr | ₹-3.70 Cr | ₹5.10 Cr | ₹1.38 Cr | ₹3.86 Cr |
| Earnings Per Share (Rs) | ₹-1.12 | ₹-1.98 | ₹-0.78 | ₹1.08 | ₹0.30 |
| PAT Margin (%) | -5.06 | -7.28 | -2.96 | 3.85 | 1.30 |
| ROE(%) | -183.25 | -91.91 | -22.22 | 32.19 | 16.47 |
| ROCE(%) | -4.18 | -14.30 | -2.32 | 16.13 | 8.94 |
| Total Debt/Equity(x) | 131.12 | 9.69 | 2.73 | 2.44 | 2.54 |
Key Financials |
||
| Market Cap | : | ₹ 195.5 Cr |
| Revenue (TTM) | : | ₹ 111.0 Cr |
| Net Profit(TTM) | : | ₹ 9.4 Cr |
| EPS (TTM) | : | ₹ 2.0 |
| P/E (TTM) | : | 20.8 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| KIMIA BIOSCIENCES | -2.8% | -6% | -19% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.5% | 9.1% | 9.1% |
| DIVIS LABORATORIES | -4.9% | -0.6% | 59.1% |
| CIPLA | -1.8% | 1% | 0.5% |
| TORRENT PHARMACEUTICALS | 1.6% | 12.1% | 21.8% |
| DR REDDYS LABORATORIES | -3% | -0.9% | -7.7% |
| MANKIND PHARMA | 1.1% | 7.6% | 1.3% |
| ZYDUS LIFESCIENCES | -2.2% | -0.6% | -9.3% |
| LUPIN | -2.7% | 1% | 30.1% |
KIMIA BIOSCIENCES Revenues
[BOM: 530313]
| Y-o-Y | 2.89 % |
| 5 Yr CAGR | 8.16 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹129 Cr | 2.89 | |
| Mar2023 | ₹125 Cr | -5.89 | |
| Mar2022 | ₹133 Cr | 24.86 | |
| Mar2021 | ₹106 Cr | 13.17 | |
| Mar2020 | ₹94 Cr | - | |
KIMIA BIOSCIENCES Operating Profit
[BOM: 530313]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹-5.09 Cr | Negative | |
| Mar2023 | ₹0.63 Cr | -92.47 | |
| Mar2022 | ₹8.38 Cr | 88.25 | |
| Mar2021 | ₹4.45 Cr | -20.13 | |
| Mar2020 | ₹5.57 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | -3.96% | Negative | |
| Mar2023 | 0.51% | -91.92 | |
| Mar2022 | 6.31% | 50.60 | |
| Mar2021 | 4.19% | -29.34 | |
| Mar2020 | 5.93% | - | |
KIMIA BIOSCIENCES Profit After Tax
[BOM: 530313]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹-9.35 Cr | Negative | |
| Mar2023 | ₹-3.70 Cr | Negative | |
| Mar2022 | ₹5.10 Cr | 269.59 | |
| Mar2021 | ₹1.38 Cr | -64.18 | |
| Mar2020 | ₹3.86 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | -5.06 % | Negative | |
| Mar2023 | -7.28 % | Negative | |
| Mar2022 | -2.96 % | Negative | |
| Mar2021 | 3.85 % | 196.15 | |
| Mar2020 | 1.3 % | - | |
KIMIA BIOSCIENCES Earnings Per Share (EPS)
[BOM: 530313]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹-1.12 | Negative | |
| Mar2023 | ₹-1.98 | Negative | |
| Mar2022 | ₹-0.78 | Negative | |
| Mar2021 | ₹1.08 | 260.00 | |
| Mar2020 | ₹0.30 | - | |
KIMIA BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 530313]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | -4.18% | Negative | |
| Mar2023 | -14.3% | Negative | |
| Mar2022 | -2.32% | Negative | |
| Mar2021 | 16.13% | 80.43 | |
| Mar2020 | 8.94% | - | |
KIMIA BIOSCIENCES Share Price vs Sensex
| Current Share Price | : | ₹41.3 |
| Current MarketCap | : | ₹ 195.5 Cr |
| Updated EOD on | : | Apr 04,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KIMIA BIOSCIENCES | -2.8% |
-6% |
-19% |
| SENSEX | -2.9% |
3.1% |
1.8% |
KIMIA BIOSCIENCES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about KIMIA BIOSCIENCES Financials
How the annual revenues of KIMIA BIOSCIENCES have changed ?
The Revenues of KIMIA BIOSCIENCES have increased by 2.89% YoY .
How the Earnings per Share (EPS) of KIMIA BIOSCIENCES have changed?
The Earnings Per Share (EPS) of KIMIA BIOSCIENCES has decreased by Negative YoY .
Check out Intrinsic Value of Peers of KIMIA BIOSCIENCES
Compare Stock Analytics of Peers of KIMIA BIOSCIENCES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
